Pneumagen Announces £4m Fundraising and Commits to Clinical Trial Development for COVID-19

By In The News
May 27, 2020 in The Headlines

Recommended Posts

In The News

Posted May 27, 2020

- Share

Posted May 27, 2020

ST ANDREWS, Scotland, May 27, 2020 /PRNewswire/ -- Pneumagen (Holdings) Ltd, focused on treating infectious diseases by targeting the human glycome, today announced a GBP £4 million investment to allow the clinical development of Neumifil for the prevention and treatment of COVID-19. The...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  220077
2. Jaydee
  16881
3. deicer
  12240
4. Kip Powick
  12239
5. dagger
  9596
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  270.4k
- Total Posts
  
  559.3k

Sign In

Pneumagen Announces £4m Fundraising and Commits to Clinical Trial Development for COVID-19

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support